Industry: Medical Devices & Consumables
Published Date: 2024-01-17
Pages: 100 Pages
Report ld: 2296734
Request Sample
Customized Report
Hepatitis B Test Strip Market Size(US$)

CAGR 2024-2030
4.3%
Market Size,2030
USD 164.8
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Hepatitis B Test Strip market was valued at US$ 124 million in 2023 and is anticipated to reach US$ 164.8 million by 2030, witnessing a CAGR of 4.3% during the forecast period 2024-2030.
North American market for Hepatitis B Test Strip is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Hepatitis B Test Strip is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Hepatitis B Test Strip include Biopanda Reagents, CTK Biotech, AccuBioTech, BTNX, Nectar Lifesciences, Hangzhou Aichek Medical Technology Co.,Ltd, Xiamen Boson Biotech Co., Ltd., Henso Medical and Goldenmed Biomedical Nantong Inc., etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Hepatitis B Test Strip, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hepatitis B Test Strip.
MARKET SEGMENTATION
REPORT SCOPE
The Hepatitis B Test Strip market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Hepatitis B Test Strip market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Hepatitis B Test Strip manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Hepatitis B Test Strip manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Hepatitis B Test Strip in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Hepatitis B Test Strip Market Overview
1.1 Product Overview and Scope of Hepatitis B Test Strip
1.2 Hepatitis B Test Strip Segment by Type
1.2.1 Global Hepatitis B Test Strip Market Value Comparison by Type (2024-2030)
1.2.2 HBcAb Test Strip
1.2.3 HBeAb Test Strip
1.2.4 HBeAg Test Strip
1.2.5 HBsAb Test Strip
1.2.6 HBsAg Test Strip
1.3 Hepatitis B Test Strip Segment by Application
1.3.1 Global Hepatitis B Test Strip Market Value by Application: (2024-2030)
1.3.2 Household
1.3.3 Hospital
1.3.4 Clinic
1.3.5 Others
1.4 Global Hepatitis B Test Strip Market Size Estimates and Forecasts
1.4.1 Global Hepatitis B Test Strip Revenue 2019-2030
1.4.2 Global Hepatitis B Test Strip Sales 2019-2030
1.4.3 Global Hepatitis B Test Strip Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Hepatitis B Test Strip Market Competition by Manufacturers
2.1 Global Hepatitis B Test Strip Sales Market Share by Manufacturers (2019-2024)
2.2 Global Hepatitis B Test Strip Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Hepatitis B Test Strip Average Price by Manufacturers (2019-2024)
2.4 Global Hepatitis B Test Strip Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Hepatitis B Test Strip, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Hepatitis B Test Strip, Product Type & Application
2.7 Hepatitis B Test Strip Market Competitive Situation and Trends
2.7.1 Hepatitis B Test Strip Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Hepatitis B Test Strip Players Market Share by Revenue
2.7.3 Global Hepatitis B Test Strip Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Hepatitis B Test Strip Retrospective Market Scenario by Region
3.1 Global Hepatitis B Test Strip Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Hepatitis B Test Strip Global Hepatitis B Test Strip Sales by Region: 2019-2030
3.2.1 Global Hepatitis B Test Strip Sales by Region: 2019-2024
3.2.2 Global Hepatitis B Test Strip Sales by Region: 2025-2030
3.3 Global Hepatitis B Test Strip Global Hepatitis B Test Strip Revenue by Region: 2019-2030
3.3.1 Global Hepatitis B Test Strip Revenue by Region: 2019-2024
3.3.2 Global Hepatitis B Test Strip Revenue by Region: 2025-2030
3.4 North America Hepatitis B Test Strip Market Facts & Figures by Country
3.4.1 North America Hepatitis B Test Strip Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Hepatitis B Test Strip Sales by Country (2019-2030)
3.4.3 North America Hepatitis B Test Strip Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Hepatitis B Test Strip Market Facts & Figures by Country
3.5.1 Europe Hepatitis B Test Strip Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Hepatitis B Test Strip Sales by Country (2019-2030)
3.5.3 Europe Hepatitis B Test Strip Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Hepatitis B Test Strip Market Facts & Figures by Country
3.6.1 Asia Pacific Hepatitis B Test Strip Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Hepatitis B Test Strip Sales by Country (2019-2030)
3.6.3 Asia Pacific Hepatitis B Test Strip Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Hepatitis B Test Strip Market Facts & Figures by Country
3.7.1 Latin America Hepatitis B Test Strip Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Hepatitis B Test Strip Sales by Country (2019-2030)
3.7.3 Latin America Hepatitis B Test Strip Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Hepatitis B Test Strip Market Facts & Figures by Country
3.8.1 Middle East and Africa Hepatitis B Test Strip Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Hepatitis B Test Strip Sales by Country (2019-2030)
3.8.3 Middle East and Africa Hepatitis B Test Strip Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Hepatitis B Test Strip Sales by Type (2019-2030)
4.1.1 Global Hepatitis B Test Strip Sales by Type (2019-2024)
4.1.2 Global Hepatitis B Test Strip Sales by Type (2025-2030)
4.1.3 Global Hepatitis B Test Strip Sales Market Share by Type (2019-2030)
4.2 Global Hepatitis B Test Strip Revenue by Type (2019-2030)
4.2.1 Global Hepatitis B Test Strip Revenue by Type (2019-2024)
4.2.2 Global Hepatitis B Test Strip Revenue by Type (2025-2030)
4.2.3 Global Hepatitis B Test Strip Revenue Market Share by Type (2019-2030)
4.3 Global Hepatitis B Test Strip Price by Type (2019-2030)
5 Segment by Application
5.1 Global Hepatitis B Test Strip Sales by Application (2019-2030)
5.1.1 Global Hepatitis B Test Strip Sales by Application (2019-2024)
5.1.2 Global Hepatitis B Test Strip Sales by Application (2025-2030)
5.1.3 Global Hepatitis B Test Strip Sales Market Share by Application (2019-2030)
5.2 Global Hepatitis B Test Strip Revenue by Application (2019-2030)
5.2.1 Global Hepatitis B Test Strip Revenue by Application (2019-2024)
5.2.2 Global Hepatitis B Test Strip Revenue by Application (2025-2030)
5.2.3 Global Hepatitis B Test Strip Revenue Market Share by Application (2019-2030)
5.3 Global Hepatitis B Test Strip Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Biopanda Reagents
6.1.1 Biopanda Reagents Corporation Information
6.1.2 Biopanda Reagents Description and Business Overview
6.1.3 Biopanda Reagents Hepatitis B Test Strip Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Biopanda Reagents Hepatitis B Test Strip Product Portfolio
6.1.5 Biopanda Reagents Recent Developments/Updates
6.2 CTK Biotech
6.2.1 CTK Biotech Corporation Information
6.2.2 CTK Biotech Description and Business Overview
6.2.3 CTK Biotech Hepatitis B Test Strip Sales, Revenue and Gross Margin (2019-2024)
6.2.4 CTK Biotech Hepatitis B Test Strip Product Portfolio
6.2.5 CTK Biotech Recent Developments/Updates
6.3 AccuBioTech
6.3.1 AccuBioTech Corporation Information
6.3.2 AccuBioTech Description and Business Overview
6.3.3 AccuBioTech Hepatitis B Test Strip Sales, Revenue and Gross Margin (2019-2024)
6.3.4 AccuBioTech Hepatitis B Test Strip Product Portfolio
6.3.5 AccuBioTech Recent Developments/Updates
6.4 BTNX
6.4.1 BTNX Corporation Information
6.4.2 BTNX Description and Business Overview
6.4.3 BTNX Hepatitis B Test Strip Sales, Revenue and Gross Margin (2019-2024)
6.4.4 BTNX Hepatitis B Test Strip Product Portfolio
6.4.5 BTNX Recent Developments/Updates
6.5 Nectar Lifesciences
6.5.1 Nectar Lifesciences Corporation Information
6.5.2 Nectar Lifesciences Description and Business Overview
6.5.3 Nectar Lifesciences Hepatitis B Test Strip Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Nectar Lifesciences Hepatitis B Test Strip Product Portfolio
6.5.5 Nectar Lifesciences Recent Developments/Updates
6.6 Hangzhou Aichek Medical Technology Co.,Ltd
6.6.1 Hangzhou Aichek Medical Technology Co.,Ltd Corporation Information
6.6.2 Hangzhou Aichek Medical Technology Co.,Ltd Description and Business Overview
6.6.3 Hangzhou Aichek Medical Technology Co.,Ltd Hepatitis B Test Strip Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Hangzhou Aichek Medical Technology Co.,Ltd Hepatitis B Test Strip Product Portfolio
6.6.5 Hangzhou Aichek Medical Technology Co.,Ltd Recent Developments/Updates
6.7 Xiamen Boson Biotech Co., Ltd.
6.6.1 Xiamen Boson Biotech Co., Ltd. Corporation Information
6.6.2 Xiamen Boson Biotech Co., Ltd. Description and Business Overview
6.6.3 Xiamen Boson Biotech Co., Ltd. Hepatitis B Test Strip Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Xiamen Boson Biotech Co., Ltd. Hepatitis B Test Strip Product Portfolio
6.7.5 Xiamen Boson Biotech Co., Ltd. Recent Developments/Updates
6.8 Henso Medical
6.8.1 Henso Medical Corporation Information
6.8.2 Henso Medical Description and Business Overview
6.8.3 Henso Medical Hepatitis B Test Strip Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Henso Medical Hepatitis B Test Strip Product Portfolio
6.8.5 Henso Medical Recent Developments/Updates
6.9 Goldenmed Biomedical Nantong Inc.
6.9.1 Goldenmed Biomedical Nantong Inc. Corporation Information
6.9.2 Goldenmed Biomedical Nantong Inc. Description and Business Overview
6.9.3 Goldenmed Biomedical Nantong Inc. Hepatitis B Test Strip Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Goldenmed Biomedical Nantong Inc. Hepatitis B Test Strip Product Portfolio
6.9.5 Goldenmed Biomedical Nantong Inc. Recent Developments/Updates
6.10 Hunan Runmei Gene Technology Co., Ltd.
6.10.1 Hunan Runmei Gene Technology Co., Ltd. Corporation Information
6.10.2 Hunan Runmei Gene Technology Co., Ltd. Description and Business Overview
6.10.3 Hunan Runmei Gene Technology Co., Ltd. Hepatitis B Test Strip Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Hunan Runmei Gene Technology Co., Ltd. Hepatitis B Test Strip Product Portfolio
6.10.5 Hunan Runmei Gene Technology Co., Ltd. Recent Developments/Updates
6.11 Zhejiang Orient Gene Biotech Co.,Ltd.
6.11.1 Zhejiang Orient Gene Biotech Co.,Ltd. Corporation Information
6.11.2 Zhejiang Orient Gene Biotech Co.,Ltd. Hepatitis B Test Strip Description and Business Overview
6.11.3 Zhejiang Orient Gene Biotech Co.,Ltd. Hepatitis B Test Strip Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Zhejiang Orient Gene Biotech Co.,Ltd. Hepatitis B Test Strip Product Portfolio
6.11.5 Zhejiang Orient Gene Biotech Co.,Ltd. Recent Developments/Updates
6.12 Nantong Egens Biotechnology Co. Ltd
6.12.1 Nantong Egens Biotechnology Co. Ltd Corporation Information
6.12.2 Nantong Egens Biotechnology Co. Ltd Hepatitis B Test Strip Description and Business Overview
6.12.3 Nantong Egens Biotechnology Co. Ltd Hepatitis B Test Strip Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Nantong Egens Biotechnology Co. Ltd Hepatitis B Test Strip Product Portfolio
6.12.5 Nantong Egens Biotechnology Co. Ltd Recent Developments/Updates
6.13 Alere
6.13.1 Alere Corporation Information
6.13.2 Alere Hepatitis B Test Strip Description and Business Overview
6.13.3 Alere Hepatitis B Test Strip Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Alere Hepatitis B Test Strip Product Portfolio
6.13.5 Alere Recent Developments/Updates
6.14 Biosynex
6.14.1 Biosynex Corporation Information
6.14.2 Biosynex Hepatitis B Test Strip Description and Business Overview
6.14.3 Biosynex Hepatitis B Test Strip Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Biosynex Hepatitis B Test Strip Product Portfolio
6.14.5 Biosynex Recent Developments/Updates
6.15 Cepheid
6.15.1 Cepheid Corporation Information
6.15.2 Cepheid Hepatitis B Test Strip Description and Business Overview
6.15.3 Cepheid Hepatitis B Test Strip Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Cepheid Hepatitis B Test Strip Product Portfolio
6.15.5 Cepheid Recent Developments/Updates
6.16 MedMira
6.16.1 MedMira Corporation Information
6.16.2 MedMira Hepatitis B Test Strip Description and Business Overview
6.16.3 MedMira Hepatitis B Test Strip Sales, Revenue and Gross Margin (2019-2024)
6.16.4 MedMira Hepatitis B Test Strip Product Portfolio
6.16.5 MedMira Recent Developments/Updates
6.17 TURKLAB
6.17.1 TURKLAB Corporation Information
6.17.2 TURKLAB Hepatitis B Test Strip Description and Business Overview
6.17.3 TURKLAB Hepatitis B Test Strip Sales, Revenue and Gross Margin (2019-2024)
6.17.4 TURKLAB Hepatitis B Test Strip Product Portfolio
6.17.5 TURKLAB Recent Developments/Updates
6.18 Shanghai Rongsheng Biotech Co., Ltd.
6.18.1 Shanghai Rongsheng Biotech Co., Ltd. Corporation Information
6.18.2 Shanghai Rongsheng Biotech Co., Ltd. Hepatitis B Test Strip Description and Business Overview
6.18.3 Shanghai Rongsheng Biotech Co., Ltd. Hepatitis B Test Strip Sales, Revenue and Gross Margin (2019-2024)
6.18.4 Shanghai Rongsheng Biotech Co., Ltd. Hepatitis B Test Strip Product Portfolio
6.18.5 Shanghai Rongsheng Biotech Co., Ltd. Recent Developments/Updates
6.19 Standard Diagnostics
6.19.1 Standard Diagnostics Corporation Information
6.19.2 Standard Diagnostics Hepatitis B Test Strip Description and Business Overview
6.19.3 Standard Diagnostics Hepatitis B Test Strip Sales, Revenue and Gross Margin (2019-2024)
6.19.4 Standard Diagnostics Hepatitis B Test Strip Product Portfolio
6.19.5 Standard Diagnostics Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Hepatitis B Test Strip Industry Chain Analysis
7.2 Hepatitis B Test Strip Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Hepatitis B Test Strip Production Mode & Process
7.4 Hepatitis B Test Strip Sales and Marketing
7.4.1 Hepatitis B Test Strip Sales Channels
7.4.2 Hepatitis B Test Strip Distributors
7.5 Hepatitis B Test Strip Customers
8 Hepatitis B Test Strip Market Dynamics
8.1 Hepatitis B Test Strip Industry Trends
8.2 Hepatitis B Test Strip Market Drivers
8.3 Hepatitis B Test Strip Market Challenges
8.4 Hepatitis B Test Strip Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global market for Hepatitis B Test Strip was estimated to be worth US$ 138 million in 2025 and is projected to reach US$ 185 million, growing at a CAGR of 4.3% from 2026 to 2032.
Published Date: 2026-06-16
Pages: 148
USD 3950.00
(Single User License)
The global Hepatitis B Test Strip market was valued at US$ 138 million in 2025 and is anticipated to reach US$ 185 million by 2032, at a CAGR of 4.3% from 2026 to 2032.
Published Date: 2026-04-17
Pages: 136
USD 2900.00
(Single User License)
The global Hepatitis B Test Strip market size was US$ 133 million in 2024 and is forecast to a readjusted size of US$ 178 million by 2031 with a CAGR of 4.3% during the forecast period 2025-2031.
Published Date: 2025-11-02
Pages: 105
USD 4250.00
(Single User License)
The global Hepatitis B Test Strip market is projected to grow from US$ 133 million in 2024 to US$ 178 million by 2031, at a CAGR of 4.3% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-11-02
Pages: 171
USD 4900.00
(Single User License)
The global market for Hepatitis B Test Strip was estimated to be worth US$ 133 million in 2024 and is forecast to a readjusted size of US$ 178 million by 2031 with a CAGR of 4.3% during the forecast period 2025-2031.
Published Date: 2025-01-13
Pages: 150
USD 3950.00
(Single User License)
The global market for Hepatitis B Test Strip was valued at US$ 133 million in the year 2024 and is projected to reach a revised size of US$ 178 million by 2031, growing at a CAGR of 4.3% during the forecast period.
Published Date: 2025-01-13
Pages: 104
USD 2900.00
(Single User License)
The global market for Hepatitis B Test Strip was estimated to be worth US$ 138 million in 2025 and is projected to reach US$ 185 million, growing at a CAGR of 4.3% from 2026 to 2032.
Published: 2026-06-16
Pages: 148
The global Hepatitis B Test Strip market was valued at US$ 138 million in 2025 and is anticipated to reach US$ 185 million by 2032, at a CAGR of 4.3% from 2026 to 2032.
Published: 2026-04-17
Pages: 136
The global Hepatitis B Test Strip market size was US$ 133 million in 2024 and is forecast to a readjusted size of US$ 178 million by 2031 with a CAGR of 4.3% during the forecast period 2025-2031.
Published: 2025-11-02
Pages: 105
The global Hepatitis B Test Strip market is projected to grow from US$ 133 million in 2024 to US$ 178 million by 2031, at a CAGR of 4.3% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-11-02
Pages: 171
The global market for Hepatitis B Test Strip was estimated to be worth US$ 133 million in 2024 and is forecast to a readjusted size of US$ 178 million by 2031 with a CAGR of 4.3% during the forecast period 2025-2031.
Published: 2025-01-13
Pages: 150
The global market for Hepatitis B Test Strip was valued at US$ 133 million in the year 2024 and is projected to reach a revised size of US$ 178 million by 2031, growing at a CAGR of 4.3% during the forecast period.
Published: 2025-01-13
Pages: 104
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
REPORT SCOPE
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now